⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001844264

Lee John Jui-Jen

Reports to the SEC for 1 company · BOSTON, MA

Transactions

7

Companies

1

Filings

3

CIK

0001844264

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-25	Decibel Therapeutics, Inc.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−147K sh	—	—	0
2023-09-25	Decibel Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−45K sh	—	—	0
2023-09-25	Decibel Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−52.5K sh	—	—	0
2023-09-25	Decibel Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−232K sh	—	—	0
2023-01-26	Decibel Therapeutics, Inc.A Award	Chief Development Officer	AAward	+120K sh	—	—	147,144
2023-01-26	Decibel Therapeutics, Inc.Stock Options (right to buy)A Award	Chief Development Officer	AAward	+45K sh	—	—	45,000
2022-02-25	Decibel Therapeutics, Inc.Stock Options (right to buy)A Award	Chief Development Officer	AAward	+52.5K sh	—	—	52,500

Recent filings

3

Accepted (ET)
Sep 254
Lee John Jui-Jen0000899243-23-019497
SEC(opens sec.gov)
Jan 304
Lee John Jui-Jen0000899243-23-002979
SEC(opens sec.gov)
Feb 284
Lee John Jui-Jen0000899243-22-008088
SEC(opens sec.gov)

Companies

1

Decibel Therapeutics, Inc.Chief Development Officer

Address

C/O DECIBEL THERAPEUTICS, INC. 1325 BOYLSTON STREET, SUITE 500

BOSTON, MA, 02215